{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Journal of Emergency Nursing, January 2021 : Clinical Articles

Activity Steps

Purpose of Activity

To provide registered professional nurses with information to increase their knowledge about current issues affecting emergency nursing practice.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the use of buprenorphine for the treatment of patients with opioid use disorder (OUD) in the emergency department.
  2. Identify potential consequences and complications of transgender-related treatments and procedures that may be encountered in the emergency department.
  3. Recognize potential complications of and the treatment for hydrofluoric (HF) acid exposure.
Price: $26.95

Credits:

  • ANCC 4.0 CH
  • DC - BON 4.0 CH
  • FL - BON 4.0 CH
  • GA - BON 4.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: JEN0121C
Published: January 2021
Expires: 12/2/2022
Required Passing Score: 7/10 (70%)
Authors:
Specialties: Emergency